BofA just reinstated coverage on HubSpot (HUBS) with a Buy rating and a $300 price target, calling the recent selloff a “recovery opportunity” for long-term investors. Translation: the stock got punished for AI disruption fears that are already baked into the valuation, while the underlying business is accelerating.
HubSpot’s shares cratered from their 2025 highs on concerns that AI would cannibalize traditional CRM software. But here’s the twist: HubSpot isn’t getting disrupted by AI — it’s weaponizing it. The company’s “Breeze” AI agent platform integrates artificial intelligence across marketing, sales, and service workflows, boosting productivity for small and medium-sized businesses. This isn’t a legacy CRM trying to bolt on AI features. It’s a modern platform designed for intelligent automation from the ground up.
The fundamentals tell the story. BofA believes HubSpot can reaccelerate revenue growth toward 20% in the near term, driven by product innovation and expanding customer adoption. Cantor Fitzgerald raised its price target to $325 in early March, citing “encouraging operating trends” and sustained momentum. Meanwhile, the stock is trading at a discount to its historical valuation despite improving fundamentals. That disconnect between price and performance is exactly what long-term investors hunt for.
Founded in June 2006 and headquartered in Cambridge, Massachusetts, HubSpot has spent nearly two decades building a CRM platform tailored for SMBs. Now it’s layering AI capabilities on top of that foundation, creating a productivity multiplier for customers. If you believe AI adoption is a secular trend (and you should), HubSpot is one of the cleanest ways to play it in the SaaS world — at a valuation that finally makes sense.
